ArticleCancers2023

Development and Validation of Pretreatment Serum Total Bilirubin as a Biomarker to Predict the Clinical Outcomes in Primary Central Nervous System Lymphoma: A Multicenter Cohort Study.

Jiazhen Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.